On Jan. 6, 2025, the U.S. FDA issued draft guidance for developers of AI-enabled medical devices to bolster the safe, effective development and marketing of these tools throughout their product ...
On January 7, 2025, FDA published a draft guidance titled “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations.” The draft guidance ...
On January 7, 2024, the U.S. Food and Drug Administration (FDA) published the draft guidance “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission ...
Earlier this month, FDA released a new draft guidance document outlining recommendations for lifecycle management and marketing submissions of AI-enabled device software functions. The guidance ...
On January 6, 2024, FDA released draft guidance on Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations (the “draft guidance”). The ...
Manufacturers are eager to incorporate artificial intelligence and machine learning technologies into a wide range of medical devices, from cardiac monitors that can spot developing heart problems to ...
Kimberlee Leonard has 22 years of experience as a freelance writer. Her work has been featured on US News and World Report, Business.com and Fit Small Business. She brings practical experience as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results